Bob Nelsen, Anne Wojcicki join $20M round for longevity startup hoping to slow down aging of the ovary

Having helped birth some of the earliest anti-aging upstarts, Bob Nelsen has found another new idea to love in the burgeoning space.

The ARCH managing director is among a syndicate pouring $20 million of Series A cash into Gameto, a New York-based biotech whose stated mission is to reprogram ovarian...

Click to view original post